Table 3.
Pharmacokinetic Parameters of DAC Suspension, DAC-unPEG-BILS, and DAC-PEG-BILS in Rat Liver Following Oral Administration (n=6)
Parameters | DAC Suspension | DAC-UnPEG-BILS | DAC-PEG-BILS |
---|---|---|---|
Cmax (ng.mL−1) | 1205±13.32 | 1596±20.39a | 1938±14.41a, b |
Tmax (h) | 2±0.09 | 2.7±0.21a | 3±0.17a, b |
AUC0–24(h.ng.mL−1) | 9673±13.69 | 20,698±16.32a | 29,895±19.39a, b |
t½ (h) | 11±0.14 | 13.46±0.14a | 15.66±0.14a, b |
CL (L.h−1) | 1.20±0.11 | 0.57±0.03a | 0.4±0.04a, b |
Notes: Values are means ± SD. Using one-way ANOVA followed by Tukey’s post-hoc test: ap<0.05 vs DAC suspension; bp<0.05 vs DAC-unPEG-BILS.